Where Will SpaceX Stock Be in 1 Year?

Space Exploration Technologies (SpaceX) shares pulled back to ~ $161 after an early post-debut spike to ~$225 (vs ~$150 IPO). The article cites $18.7B revenue in 2025 (+34% YoY) and $4.7B in Q1 2026 (+16% YoY), with forecasts for ~85% revenue growth in 2027 and a projected turn to profitability. Despite growth prospects, the stock is described as overvalued at a trailing P/S of ~106 (vs Tesla ~15x and Micron ~12x), implying the premium multiple is more likely to compress than expand over the next 12 months, suggesting a probable pullback.

Analysis

SPCX is vulnerable to a classic duration reset: when the market is paying for very far-dated growth, the stock’s path is driven less by current revenue momentum than by whether investors keep underwriting a perpetual scarcity premium. In the next 2-6 weeks, the main risk is not an earnings miss but a simple repricing from “must-own” to “nice story,” which can compress the multiple even if the company keeps growing.

The second-order read-through is to other premium narrative names, especially PLTR, where valuation support depends on the market tolerating very high forward sales and/or earnings multiples. NVDA and MU are less exposed because their re-ratings are anchored to earnings and cash generation, not to a private-market-style optionality narrative; if anything, any factor rotation out of long-duration growth should marginally favor those names versus PLTR on a relative basis. TSLA is a looser sympathy trade only through the Musk complex; there is no obvious operational linkage.

The contrarian view is that the crowd may be over-anchored on the headline multiple and underweight the possibility that growth alone can “earn into” the valuation over 6-18 months if revenue re-accelerates and profitability arrives on schedule. What would falsify the bearish valuation thesis is sustained post-debut price strength plus another print that confirms accelerated growth and a clean path to positive earnings; absent that, the burden of proof stays on the bulls.

Key Decisions for Investors

• Treat SPCX as a valuation-alert, not a chase: wait for 2-4 weeks of post-debut trading to see whether the stock can hold above its recent high; if it fails, expect multiple compression to continue over the next 1-3 months.
• If SPCX is borrowable, consider a small tactical short into strength with a tight stop above the recent post-debut high; risk/reward is attractive only if liquidity is adequate, because the upside gap risk is still large.
• Relative-value rotation: favor NVDA or MU over PLTR on any broader premium-growth de-rating over the next 1-3 months; the thesis is that earnings-backed comp names should outperform narrative-heavy names if factor pressure broadens.
• Do not use TSLA as a primary hedge unless the whole Musk complex sells off; it is a weaker proxy and the linkage is sentiment-only, so it is a lower-conviction relative-value expression.